RecruitingNot ApplicableNCT06446661

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Improving Oral Chemotherapy Adherence in Maintenance for Adolescents and Adults With Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma Using Text Messages

Sponsor

University of Chicago

Enrollment

48 participants

Start Date

May 19, 2026

Study Type

INTERVENTIONAL

Conditions

Acute Lymphoblastic Leukemia T-Cell Lymphoblastic Lymphoma

Summary

This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.

Eligibility

Min Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying High Intensity, Low Intensity Text Messaging, and others for people with acute lymphoblastic leukemia and t-cell lymphoblastic lymphoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 15 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.